PUF60-SCRIB fusion transcript in a patient with 8q24.3 microdeletion and atypical Verheij syndrome.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 11 06 2018
revised: 04 10 2018
accepted: 22 11 2018
pubmed: 26 11 2018
medline: 13 3 2020
entrez: 26 11 2018
Statut: ppublish

Résumé

Expression of the fusion genes is considered to be an important mechanism of tumorigenesis. However it is hardly ever discussed in relation to the neurodevelopmental disorders. Here we report on an 18-years-old female patient with 13.1 kb deletion of 8q24.3 fusing the 5'-portion of SCRIB with the 3'-portion of PUF60 and presenting with borderline intellectual disability, eye coloboma, short stature, scoliosis, heart defects and interestingly postnatal megalencephaly, in contrast to microcephaly, which is usually associated with 8q24.3 deletion (Verheij syndrome). Using next generation sequencing we mapped the breakpoints at nucleotide resolution and showed that the deletion preserved the reading frame. In contrast to the laborious techniques previously used for the precise mapping of deletion breakpoints, our approach identified an accurate interval very rapidly. We demonstrated the expression of the PUF60-SCRIB fusion gene in patient's cells and suggest that the fusion transcript might be a cause of the atypical clinical presentation.

Identifiants

pubmed: 30472487
pii: S1769-7212(18)30367-7
doi: 10.1016/j.ejmg.2018.11.021
pii:
doi:

Substances chimiques

Membrane Proteins 0
RNA Splicing Factors 0
RNA, Messenger 0
Repressor Proteins 0
SCRIB protein, human 0
Tumor Suppressor Proteins 0
poly-U binding splicing factor 60KDa 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103587

Informations de copyright

Copyright © 2018. Published by Elsevier Masson SAS.

Auteurs

D Abdin (D)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany; Human Cytogenetics Department, National Research Centre, Cairo, Egypt. Electronic address: dalia.abdin@uniklinikum-dresden.de.

A Rump (A)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany.

A Tzschach (A)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany.

K Sarnow (K)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany.

E Schröck (E)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany.

K Hackmann (K)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany.

N Di Donato (N)

Institute for Clinical Genetics, Faculty of Medicine Carl Gustav Carus, TU Dresden, Germany. Electronic address: nataliya.didonato@uniklinikum-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH